Morphology builds on NovaSignal’s mission to unlock the power of cerebral blood flow data for all healthcare practitioners
NovaGuide, the only autonomous transcranial Doppler ultrasound, is approved for use in Canada.
Clinical trial data presented in late-breaking science session at the American Heart Association International Stroke Conference 2022 show NovaGuide is three times more likely to detect RLS than standard of care transthoracic echocardiography.
As part of an exciting update to the NovaSignal Platform, we are pleased to announce to launch of Morphology. Morphology provides physicians with advanced analysis of cerebral waveforms to enable faster and easier assessment of patients with suspected neurological conditions, including stroke.
Clinical trial results show NovaGuide™ is three times more likely to detect RLS than transthoracic echocardiography Data presented in late-breaking science session at International Stroke Conference 2022
Every year nearly 800,000 people in the US have a stroke. Around 10 to 20 percent of strokes are due to carotid artery disease and more than 100,000 carotid revascularization procedures are performed every year. Without the help of cerebral blood flow monitoring, inadequate blood supply, dangerous embolization, and hyperperfusion can go unseen by the surgical team. Download the case to learn how the real-time blood flow data provided by the NovaSignal Platform allows clinicians to immediately respond to perioperative concerns.
More than 75% of the global burden of SCD occurs in sub-Saharan Africa, where an estimated 1.03 million children are afflicted. Learn more about how Dr. Nicole O’Brien and Nationwide Children’s Hospital is using TCD to help treat SCD in Africa!